Similarities between neurologic effects of L-dopa and of apomorphine.
D000328:Adult; D001058:Apomorphine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects; D002648:Child; D002986:Clinical Trials as Topic; D003486:Cyanides / Q000506:poisoning; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D020149:Manganese Poisoning; D009135:Muscular Diseases / Q000188:drug therapy; D009461:Neurologic Manifestations; D010300:Parkinson Disease / Q000188:drug therapy; D010919:Placebos; D011041:Poisoning / Q000188:drug therapy
D003486:Cyanides; D010919:Placebos; D004295:Dihydroxyphenylalanine; D001058:Apomorphine